NasdaqCM - Nasdaq Real Time Price USD

Champions Oncology, Inc. (CSBR)

5.06 0.00 (0.00%)
As of April 25 at 4:00 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Ronnie Morris M.D. CEO & Director 600k -- 1966
Mr. David Barry Miller M.B.A. Chief Financial Officer 285k -- 1969
Mr. Brady Davis President -- -- --
Dr. Maria Mancini Ph.D. Chief Operating Officer -- -- --
Mr. Arthur Hanson Vice President of Technology -- -- --
Ms. Rachel A. Bunting M.B.A., M.S., MBA, MS VP of Global Marketing -- -- --
Mr. David DeOrnellis BS, CMAR, CPIA, RLATG Executive Vice President of Global Laboratory Operations -- -- --
Dr. Michael Ritchie M.B.A., Ph.D. Chief Commercial Officer -- -- --
Dr. Karin Abarca Heidemann Ph.D. Executive Vice President of Global Scientific Operations -- -- --
Dr. Marianna Zipeto Ph.D. Executive Vice President of Commercial, Research Services & Partnering -- -- --

Champions Oncology, Inc.

One University Plaza
Suite 307
Hackensack, NJ 07601
United States
201 808 8400 https://www.championsoncology.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
230

Description

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Corporate Governance

Champions Oncology, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Jul 22, 2024 - Jul 26, 2024
Champions Oncology, Inc. Earnings Call

Related Tickers